Body mass, chronic heart failure, surgery and survival

被引:9
作者
Clark, Andrew L. [1 ]
Anker, Stefan D. [2 ]
机构
[1] Castle Hill Hosp, Dept Acad Cardiol, Kingston Upon Hull 16 5JQ, N Humberside, England
[2] Campus Virchow Klinikum, Charite, Berlin, Germany
关键词
cardiac cachexia; mechanical support; heart failure; outcome; TUMOR-NECROSIS-FACTOR; CARDIAC SURGICAL PATIENTS; PROGNOSTIC IMPORTANCE; METABOLIC RESPONSE; BETA-BLOCKERS; RISK-FACTORS; MORTALITY; WEIGHT; CACHEXIA; OBESITY;
D O I
10.1016/j.healun.2009.07.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiac cachexia, associated with excessive activation of the sympathetic nervous system together with immune activation, is an important prognostic indicator in heart failure. Anecdotally, the prevalence of cardiac cachexia appears to be falling, perhaps due to the increased use of beta-blockers. However, chronic heart failure is so common that many patients continue to lose weight and continue to deteriorate to a point where transplantation or mechanical support is considered. The origin of cachexia remains elusive and further research is needed to explore the relation between weight, sympathetic activation, and the response to cardiac surgery or transplantation. J Heart Lung Transplant 2010;29:261-4 (C) 2010 International Society for Heart and Lung Transplantation. All rights reserved.
引用
收藏
页码:261 / 264
页数:4
相关论文
共 40 条
[1]  
ABEL RM, 1976, ARCH SURG-CHICAGO, V111, P45
[2]   Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study [J].
Anker, SD ;
Negassa, A ;
Coats, AJS ;
Afzal, R ;
Poole-Wilson, PA ;
Cohn, JN ;
Yusuf, S .
LANCET, 2003, 361 (9363) :1077-1083
[3]   Wasting as independent risk factor for mortality in chronic heart failure [J].
Anker, SD ;
Ponikowski, P ;
Varney, S ;
Chua, TP ;
Clark, AL ;
WebbPeploe, KM ;
Harrington, D ;
Kox, WJ ;
PooleWilson, PA ;
Coats, AJS .
LANCET, 1997, 349 (9058) :1050-1053
[4]  
Anker SD, 1997, CIRCULATION, V96, P526
[5]   Catabolism in chronic heart failure [J].
Berry, C ;
Clark, AL .
EUROPEAN HEART JOURNAL, 2000, 21 (07) :521-532
[6]   COMBINED HORMONAL INFUSION SIMULATES THE METABOLIC RESPONSE TO INJURY [J].
BESSEY, PQ ;
WATTERS, JM ;
AOKI, TT ;
WILMORE, DW .
ANNALS OF SURGERY, 1984, 200 (03) :264-281
[7]   Myotoxic effects of clenbuterol in the rat heart and soleus muscle [J].
Burniston, JG ;
Ng, Y ;
Clark, WA ;
Colyer, J ;
Tan, LB ;
Goldspink, DF .
JOURNAL OF APPLIED PHYSIOLOGY, 2002, 93 (05) :1824-1832
[8]  
Carrier M, 1998, CAN J CARDIOL, V14, P703
[9]   Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure -: Results of the Anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial [J].
Chung, ES ;
Packer, M ;
Lo, KH ;
Fasanmade, AA ;
Willerson, JT .
CIRCULATION, 2003, 107 (25) :3133-3140
[10]   Ventricular assist device in severe heart failure - Effects on cytokines, complement and body weight [J].
Clark, AL ;
Leobe, M ;
Potapov, EV ;
Egerer, K ;
Knosalla, C ;
Hetzer, R ;
Anker, SD .
EUROPEAN HEART JOURNAL, 2001, 22 (24) :2275-2283